{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T04:03:07Z","timestamp":1784952187000,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100018695","name":"HORIZON EUROPE Research Infrastructures","doi-asserted-by":"publisher","award":["RD16\/0025\/0010"],"award-info":[{"award-number":["RD16\/0025\/0010"]}],"id":[{"id":"10.13039\/100018695","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CM21\/00263"],"award-info":[{"award-number":["CM21\/00263"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CM19\/00251"],"award-info":[{"award-number":["CM19\/00251"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["B-0061-2021"],"award-info":[{"award-number":["B-0061-2021"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD16\/0025\/0010"],"award-info":[{"award-number":["RD16\/0025\/0010"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jinf.2022.11.004","type":"journal-article","created":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T02:06:19Z","timestamp":1668823579000},"page":"41-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Burden of significant liver damage in people living with HIV after microelimination of the hepatitis C virus"],"prefix":"10.1016","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7135-3247","authenticated-orcid":false,"given":"M.","family":"Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Corma-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fernandez-Fuertes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gonz\u00e1lez-Serna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Rinc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4932-7429","authenticated-orcid":false,"given":"L.M.","family":"Real","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Pineda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mac\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2022.11.004_bib0001","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.cmi.2020.10.023","article-title":"Progression to hepatitis C virus micro-elimination in people living with HIV in Spain","volume":"27","author":"Rivero-Juarez","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2022.11.004_bib0002","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/hiv.13039","article-title":"Incidence of recently acquired hepatitis C virus infection among HIV-infected patients in southern Spain","volume":"22","author":"Gonzalez-Serna","year":"2021","journal-title":"HIV Med"},{"key":"10.1016\/j.jinf.2022.11.004_bib0003","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2021.26.25.2000236","article-title":"HIV\/HBV coinfection: temporal trends and patient characteristics, Spain, 2002 to 2018","volume":"26","author":"P\u00e9rez-Latorre","year":"2021","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.jinf.2022.11.004_bib0004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148104","article-title":"Liver toxicity of current antiretroviral regimens in HIV-infected patients with chronic viral hepatitis in a real-life setting: the HEPAVIR SEG-HEP cohort","volume":"11","author":"Neukam","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2022.11.004_bib0005","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/QAD.0000000000000248","article-title":"Prevalence and factors associated with liver steatosis as measured by transient elastography with controlled attenuation parameter in HIV-infected patients","volume":"28","author":"Mac\u00edas","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2022.11.004_bib0006","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S2468-1253(16)30081-4","article-title":"Screening for liver fibrosis in the general population: a call for action","volume":"1","author":"Gines","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jinf.2022.11.004_bib0007","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S2468-1253(18)30077-3","article-title":"Non-alcoholic fatty liver disease and the interface between primary and secondary care","volume":"3","author":"Tsochatzis","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jinf.2022.11.004_bib0008","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1001\/archinte.158.16.1789","article-title":"The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking","volume":"158","author":"Bush","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jinf.2022.11.004_bib0009","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.cgh.2017.12.048","article-title":"High prevalence of liver fibrosis among European adults with unknown liver disease: a population-based study","volume":"16","author":"Caballer\u00eda","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jinf.2022.11.004_bib0010","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.eimc.2012.12.004","article-title":"Sustained virological response to pegylated interferon plus ribavirin leads to normalization of liver stiffness in hepatitis C virus-infected patients","volume":"31","author":"Macias","year":"2013","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.jinf.2022.11.004_bib0011","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1097\/QAD.0000000000000787","article-title":"Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV\/HCV-coinfected patients","volume":"29","author":"Salmon","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2022.11.004_bib0012","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1093\/cid\/ciz1140","article-title":"Liver stiffness at the time of sustained virological response predicts the clinical outcome in people living with human immunodeficiency virus and hepatitis C virus with advanced fibrosis treated with direct-acting antivirals","volume":"71","author":"Mac\u00edas","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2022.11.004_bib0013","doi-asserted-by":"crossref","first-page":"e2109","DOI":"10.1093\/cid\/ciaa1111","article-title":"Human Immunodeficiency Virus (HIV) infection is associated with lower risk of hepatocellular carcinoma after sustained virological response to direct-acting antivirals in hepatitis C infected patients with advanced fibrosis","volume":"73","author":"Corma-G\u00f3mez","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2022.11.004_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101771","article-title":"Non-invasive diagnosis and follow-up of chronic infection with hepatitis C Virus","volume":"46","author":"Tran","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jinf.2022.11.004_bib0015","doi-asserted-by":"crossref","first-page":"138","DOI":"10.14309\/ajg.0000000000001503","article-title":"A 2-step strategy combining FIB-4 with transient elastography and ultrasound predicted liver cancer after HCV cure","volume":"117","author":"Ampuero","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jinf.2022.11.004_bib0016","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","author":"Lampertico","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jinf.2022.11.004_bib0017","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.3390\/cancers13235892","article-title":"Novel liver stiffness-based nomogram for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection initiating antiviral therapy","volume":"13","author":"Lee","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jinf.2022.11.004_bib0018","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2022.11.004_bib0019","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/liv.14844","article-title":"New drugs for NASH","volume":"41","author":"Albhaisi","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.jinf.2022.11.004_bib0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12876-020-01230-1","article-title":"Causative factors of liver fibrosis in HIV-infected patients. A single center study","volume":"20","author":"Androutsakos","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jinf.2022.11.004_bib0021","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3748\/wjg.v24.i11.1269","article-title":"Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals","volume":"24","author":"Noureddin","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jinf.2022.11.004_bib0022","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/hiv.13229","article-title":"Epidemiological trends of HIV\/HCV coinfection in Spain, 2015-2019","volume":"23","author":"Fanciulli","year":"2022","journal-title":"HIV Med"},{"key":"10.1016\/j.jinf.2022.11.004_bib0023","series-title":"Abstracts From CROI 2022 Conference on Retroviruses and Opportunistic Infections. CROI 2022 Abstract eBook","first-page":"214","article-title":"Etiology of liver disease in adults with HIV in low and middle-income countries [CROI abstract 549]","author":"Plaisy","year":"2022"},{"key":"10.1016\/j.jinf.2022.11.004_bib0024","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/QCO.0b013e32835635df","article-title":"Coinfection by human immunodeficiency virus and hepatitis C virus: noninvasive assessment and staging of fibrosis","volume":"25","author":"Resino","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jinf.2022.11.004_bib0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/liv.15099","article-title":"Gamma-Glutamyl Transferase (\u03b3-GT) \u2013 an old dog with new tricks?","volume":"42","author":"Brennan","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.jinf.2022.11.004_bib0026","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jhep.2019.08.019","article-title":"Transient elastography for screening of liver fibrosis: cost-effectiveness analysis from six prospective cohorts in Europe and Asia","volume":"71","author":"Serra-Burriel","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jinf.2022.11.004_bib0027","doi-asserted-by":"crossref","first-page":"209","DOI":"10.14740\/gr1377","volume":"14","author":"Ajao","year":"2021","journal-title":"Gastroenterol Res"},{"key":"10.1016\/j.jinf.2022.11.004_bib0028","article-title":"Journal pre-proof low accuracy of FIB-4 and NAFLD fibrosis scores for screening for liver fibrosis in the population","author":"Graupera","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jinf.2022.11.004_bib0029","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1086\/521857","article-title":"The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection","volume":"45","author":"Vergara","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2022.11.004_bib0030","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/apt.13488","article-title":"Systematic review with meta-analysis: the diagnostic accuracy of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B","volume":"43","author":"Li","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jinf.2022.11.004_bib0031","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","author":"Wong","year":"2010","journal-title":"Hepatology"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445322006454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445322006454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:00:53Z","timestamp":1777492853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445322006454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0163445322006454"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2022.11.004","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Burden of significant liver damage in people living with HIV after microelimination of the hepatitis C virus","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2022.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}